News

India Introduces New BPaLM Regimen to Combat Drug-Resistant Tuberculosis, Aiming for TB-Free Nation by 2025

New Delhi: In a significant move towards eliminating tuberculosis (TB) in India by 2025, five years ahead of the global target, the Union Ministry of Health & Family Welfare has approved the introduction of the BPaLM regimen—a groundbreaking treatment for Multi-Drug-Resistant Tuberculosis (MDR-TB). This innovative regimen, introduced under the National TB Elimination Program (NTEP), offers a shorter and more effective treatment option for the country’s 75,000 drug-resistant TB patients.

The BPaLM regimen combines four drugs: Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin. Pretomanid, a key component of this combination, has been licensed for use in India by the Central Drugs Standard Control Organization (CDSCO) and is expected to significantly enhance the country’s fight against MDR-TB. The regimen provides a highly effective and safe alternative to traditional treatments, reducing the treatment duration from up to 20 months to just six months, with fewer side effects and a higher success rate.

Health experts have validated the new treatment through a thorough review, and a Health Technology Assessment confirmed that the BPaLM regimen is not only safe but also cost-effective, ensuring better outcomes for patients and healthcare systems.

The Government of India’s decision to introduce the BPaLM regimen aligns with Prime Minister Narendra Modi’s vision to rid the country of TB by 2025. This ambitious target comes well ahead of the global goal set under the Sustainable Development Goals (SDGs). By rolling out this new treatment, the government aims to accelerate progress toward ending TB nationwide.

A country-wide, time-bound rollout plan for the BPaLM regimen is being developed by the Central TB Division in consultation with state and union territories (UTs). The plan includes extensive training and capacity building for healthcare professionals to ensure the safe and effective administration of the new treatment across the country.

Bureau The News Hashtag

Recent Posts

East Coast Railway to Double Drone Fleet to 22 by March 2027

Bhubaneswar: East Coast Railway (ECoR) is expanding its technology-driven security network, with plans to increase…

19 hours ago

Odisha’s Traditional Weaves and Crafts Shine at Bhubaneswar Times Fashion Week 2026

Bhubaneswar: Odisha’s traditional handloom and handicraft heritage took centre stage at Bhubaneswar Times Fashion Week…

22 hours ago

Odisha Prepares for Physical Tests of 4,683 Candidates in Forest, Excise Recruitment

Bhubaneswar: With physical tests for the recruitment of Foresters, Forest Guards and Excise Constables set…

3 days ago

AI, Deepfakes and Misinformation Pose New Challenges for Govt Communication: Expert

Bhubaneswar: Adapting government communication to the rapidly evolving digital and artificial intelligence (AI) landscape while…

3 days ago

ECoR Honours Olympian Amit Rohidas for Contribution to India’s Asian Games Gold

Bhubaneswar: Olympian hockey player and East Coast Railway (ECoR) Sports Officer Amit Rohidas was felicitated…

3 days ago

Odisha Launches Poultry Farming Scheme with Subsidy of Up to ₹10 Crore

Bhubaneswar: In a major push to expand egg production and attract investment in the poultry…

3 days ago